All In Biotech

Drug Trial Radar · NCT06095102

A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 311 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

311

Actual

Start

Oct 12, 2023

Primary completion

Jun 19, 2024

Study completion Feb 17, 2027

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Oct 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/or palms of the hands and the soles of the feet).

Conditions

  • Plaque Psoriasis

Interventions

  • JNJ-77242113Drug

    JNJ-77242113 will be administered orally.

  • PlaceboDrug

    Placebo will be administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved an Investigator's Global Assessment (IGA) Score of 0 or 1 and a Greater Than or Equal to (>=) 2-Grade Improvement From Baseline at Week 16Time frame: Week 16

Locations

90 sites in 11 countries. Site status is shown where the registry gives one.

  • Center for Dermatology and Plastic Surgery

    Scottsdale, Arizona

  • Johnson Dermatology

    Fort Smith, Arkansas

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • Forcare Clinical Research Inc

    Tampa, Florida

  • Hamilton Research LLC

    Alpharetta, Georgia

  • Arlington Dermatology

    Rolling Meadows, Illinois

  • Dundee Dermatology

    West Dundee, Illinois

  • Dawes Fretzin Clinical Research Group LLC

    Indianapolis, Indiana

  • Indiana Clinical Trial Center

    Plainfield, Indiana

  • Dermatology and Advanced Aesthetics

    Lake Charles, Louisiana

  • Allcutis Research 1

    Beverly, Massachusetts

  • Hamzavi Dermatology

    Fort Gratiot, Michigan

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • MediSearch Clinical Trials

    Saint Joseph, Missouri

  • Skin Specialists

    Omaha, Nebraska

  • Schweiger Dermatology Group

    East Windsor, New Jersey

  • Optima Research

    Boardman, Ohio

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • Paddington Testing Co, Inc.

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Arlington Research Center, Inc.

    Arlington, Texas

  • Center for Clinical Studies 1

    Houston, Texas

  • Austin Institute for Clinical Research

    Pflugerville, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Dermatology Clinical Research Center of San Antonio

    San Antonio, Texas

  • Center for Clinical Studies

    Webster, Texas

  • Cope Family Medicine - Ogden Clinic

    Bountiful, Utah

  • Frontier Derm Partners CRO, LLC

    Mill Creek, Washington

  • CIPREC

    Buenos Aires, Argentina

  • Centro Privado de Medicina Familiar

    Buenos Aires, Argentina

  • CEDIC Centro de Investigacion clinica

    Caba, Argentina

  • Conexa Investigacion Clinica S.A.

    CABA, Argentina

  • Alberta DermaSurgery Centre

    Edmonton, Alberta, Canada

  • Lynderm Research Inc.

    Markham, Ontario, Canada

  • Skin Centre for Dermatology

    Peterborough, Ontario, Canada

  • York Dermatology Clinic and Research Centre

    Richmond Hill, Ontario, Canada

  • Innovaderm Research Inc.

    Montreal, Quebec, Canada

  • Centre De Recherche Dermatologique Du Quebec Metropolitain

    Québec, Quebec, Canada

  • Skinsense Medical Research

    Saskatoon, Saskatchewan, Canada

  • ISA - Interdisciplinary Study Association GmbH

    Berlin, Germany

Showing 40 of 90 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.